Share on StockTwits

Enzymotec (NASDAQ:ENZY) issued its quarterly earnings data on Wednesday. The company reported $0.24 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.17 by $0.07, Stock Ratings Network reports. The company had revenue of $23.70 million for the quarter, compared to the consensus estimate of $19.40 million.

On the ratings front, analysts at Zacks upgraded shares of Enzymotec from a “neutral” rating to an “outperform” rating in a research note on Thursday, February 20th. They now have a $28.20 price target on the stock. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $26.80.

Enzymotec (NASDAQ:ENZY) opened at 20.23 on Wednesday. Enzymotec has a 52-week low of $14.25 and a 52-week high of $35.12. The stock’s 50-day moving average is $20.29 and its 200-day moving average is $25.09.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.